Ethylene

Ethylene

SCHEMBL8908925

C=C.O=C1c2ccccc2-c2[nH]c(=O)cnc21

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
POLB P06746 2/20 0.50
RXFP1 Q9HBX9 1/20 0.50
USP8 P40818 2/20 0.46
USP7 Q93009 1/20 0.46
IDO1 P14902 7/20 0.42
PTPRC P08575 2/20 0.42
CTSL P07711 1/20 0.42
CTSS P25774 1/20 0.42
PTPN13 Q12923 1/20 0.42
TDO2 P48775 1/20 0.41
RAB9A P51151 2/20 0.41
APAF1 O14727 1/20 0.41
PAX8 Q06710 1/20 0.41
KMT2A Q03164 1/20 0.40
USP2 O75604 1/20 0.39
USP1 O94782 1/20 0.39
OTUB1 Q96FW1 1/20 0.39
USP36 Q9P275 1/20 0.39
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8908559 0.96 ALDH1A1 (0.53) ALDH1A1POLBRXFP1USP8USP7
SCHEMBL6237073 0.89 POLB (0.58) ALDH1A1POLBRXFP1IDO1PTPRC
SCHEMBL9815972 0.85 PTPRC (0.42) ALDH1A1POLBRXFP1USP8USP7
SCHEMBL8908230 0.76 KMT2A (0.41) ALDH1A1POLBRXFP1USP8USP7
SCHEMBL8908233 0.76 KMT2A (0.41) ALDH1A1POLBRXFP1USP8USP7
SCHEMBL1888851 0.69 KDM4E (0.52) ALDH1A1POLBRAB9AKMT2ANPC1
SCHEMBL30204979 0.67 ALDH1A1 (1.00) ALDH1A1POLBRXFP1IDO1PTPRC
SCHEMBL414535 0.67 ALDH1A1 (1.00) ALDH1A1POLBRXFP1IDO1PTPRC
Anthraquinone SCHEMBL28787967 0.67 ALDH1A1 (0.50) ALDH1A1POLBIDO1RAB9AKMT2A
Anthraquinone SCHEMBL28141482 0.65 MEN1 (0.86) ALDH1A1POLBIDO1PTPRCRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0682657-B1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE NOVO NORDISK AS (DK) 1997-11-19 EP claimed
EP-0682657-A1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1995-11-22 EP claimed
US-5468748-A Nervous system and psychological disorders; antagonize glycine binding site on N-methylaspartic acid receptor complex NOVO NORDISK A/S (DK) 1995-11-21 US claimed
WO-1994018175-A1 HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1994-08-18 WO claimed
EP-0682657-B1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE NOVO NORDISK AS (DK) 1997-11-19 EP disclosed
US-5646146-A CENTRAL NERVOUS SYSTEM DISORDERS NOVO NORDISK A/S (DK) 1997-07-08 US disclosed
EP-0682657-A1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1995-11-22 EP disclosed
US-5468748-A Nervous system and psychological disorders; antagonize glycine binding site on N-methylaspartic acid receptor complex NOVO NORDISK A/S (DK) 1995-11-21 US disclosed
WO-1994018175-A1 HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1994-08-18 WO disclosed